NCT06974136

Brief Summary

This project investigates the efficacy of transcranial electrical stimulation (tES) modalities, specifically transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS), for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Mar 2025Jul 2026

Study Start

First participant enrolled

March 30, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 30, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 15, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

May 15, 2025

Status Verified

May 1, 2025

Enrollment Period

11 months

First QC Date

April 30, 2025

Last Update Submit

May 8, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • ADHD symptoms- Clinical rating scale

    ADHD symptoms will be assessed using a DSM-based structured interview. This approach involves a systematic, standardized method to evaluate the presence and severity of ADHD symptoms based on the diagnostic criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM), likely the DSM-5, which is widely used for diagnosing ADHD.

    Baseline, week 2, up to 1 month after the intervention

Secondary Outcomes (3)

  • Executive function- Performance accuracy and reaction time

    Baseline, week 2, up to 1 month after the intervention

  • electroencephalogram (EEG) power

    Baseline, week 2

  • electroencephalogram (EEG) functional connectivity

    Baseline, week 2

Study Arms (3)

active tDCS group

ACTIVE COMPARATOR

This group receives Transcranial Direct Current Stimulation (tDCS). tDCS delivers a constant, low-intensity direct current (typically 1-2 mA) through electrodes placed on the scalp. The anode (positive electrode) increases cortical excitability by depolarizing neurons, while the cathode (negative electrode) decreases excitability by hyperpolarizing neurons.

Device: transcranial electrical stimulation

active tACS group

ACTIVE COMPARATOR

This group receives Transcranial Alternating Current Stimulation (tACS). tACS applies an oscillating current at specific frequencies (e.g., 1-100 Hz) to entrain or synchronize neural oscillations. By aligning the stimulation frequency with endogenous brain rhythms (e.g., theta or gamma bands), tACS can modulate network dynamics, potentially normalizing aberrant oscillatory patterns associated with disorders like ADHD.

Device: transcranial electrical stimulation

sham group

PLACEBO COMPARATOR

This group receives sham stimulation. The stimulation duration is for 1 minuetand the device will be turned off after the stimulation

Device: transcranial electrical stimulation

Interventions

Transcranial electrical stimulation (tES) is a non-invasive neuromodulation technique that applies low-intensity electrical currents to the scalp to modulate brain activity. It targets specific brain regions to influence neuronal excitability, connectivity, and plasticity, offering potential therapeutic benefits for neurological and psychiatric conditions. tES is portable, cost-effective, and generally well-tolerated, with minimal side effects such as mild tingling or itching at the stimulation site.

Also known as: tDCS, tACS
active tACS groupactive tDCS groupsham group

Eligibility Criteria

Age7 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosis of ADHD by a licensed psychiatrist and a behavioral checklist
  • being 7-18 years old
  • providing written informed consent signed by parents

You may not qualify if:

  • comorbidity with other neurodevelopmental disorders
  • Comorbidity with other neurological disorders
  • previous history of neurosurgery
  • Presence of any ferromagnetic metal in the head
  • implanted medical devices in the head or neck region
  • history of non-controlled epilepsy with seizures in the last year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute for Research in Fundamental Sciences

Tehran, Iran

RECRUITING

MeSH Terms

Conditions

Attention Deficit Disorder with HyperactivityNeurodevelopmental Disorders

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Central Study Contacts

Mohammad Ali Salehinejad Haghighi

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 30, 2025

First Posted

May 15, 2025

Study Start

March 30, 2025

Primary Completion

March 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

May 15, 2025

Record last verified: 2025-05

Locations